Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The pluripotent factor OCT4A enhances the self-renewal of human dental pulp stem cells by targeting lncRNA FTX in an LPS-induced inflammatory microenvironment. | Stem Cell Res Ther | 2023 | 37106382 | PubTator, text mining | PubMed |
| Technical failure rates for biometry between swept-source and older-generation optical coherence methods: a review and meta-analysis. | BMC Ophthalmol | 2023 | 37101115 | PubTator, text mining | PubMed |
| Adaptive spectroscopic visible-light optical coherence tomography for clinical retinal oximetry. | Commun Med (Lond) | 2023 | 37095177 | PubTator, text mining | PubMed |
| Prediction for Plasma Trough Concentration and Optimal Dosing of Imatinib under Multiple Clinical Situations Using Physiologically Based Pharmacokinetic Modeling. | ACS Omega | 2023 | 37091368 | PubTator, text mining | PubMed |
| Nanobody inhibitors of Plexin-B1 identify allostery in plexin-semaphorin interactions and signaling. | J Biol Chem | 2023 | 37088134 | PubTator, text mining | PubMed |
| Longitudinal quantification of choriocapillaris flow deficits in persistent placoid maculopathy: a case report. | BMC Ophthalmol | 2023 | 37072720 | PubTator, text mining | PubMed |
| [Long-term outcomes of treating rhegmatogenous retinal detachment with macular hole using platelet-rich blood plasma]. | Vestn Oftalmol | 2023 | 37067926 | PubTator, text mining | PubMed |
| Longitudinal Observation of Retinal Response to Optic Nerve Transection in Rats Using Visible Light Optical Coherence Tomography. | Invest Ophthalmol Vis Sci | 2023 | 37057973 | PubTator, text mining | PubMed |
| Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies. | Front Pediatr | 2023 | 37051435 | PubTator, text mining | PubMed |
| Early Retinal Microvascular Changes Assessed with Swept-Source OCT Angiography in Type 1 Diabetes Patients without Retinopathy. | J Clin Med | 2023 | 37048770 | PubTator, text mining | PubMed |
| Radiation-Induced Retinopathy and Optic Neuropathy after Radiation Therapy for Brain, Head, and Neck Tumors: A Systematic Review. | Cancers (Basel) | 2023 | 37046660 | PubTator, text mining | PubMed |
| Scalable generation of sensory neurons from human pluripotent stem cells. | Stem Cell Reports | 2023 | 37044067 | PubTator, text mining | PubMed |
Efficacy and safety of laser peripheral iridoplasty with different energy levels and locations in the treatment of primary angle closure disease assessed by swept-source anterior segment optical coherence tomography. | BMC Ophthalmol | 2023 | 37041488 | PubTator, text mining | PubMed |
| THE LONG-TERM FOLLOW-UP OF AUTOLOGOUS BLOOD CLOT-ASSISTED LYOPHILIZED HUMAN AMNIOTIC MEMBRANE COVERING TREATMENT UNCLOSED MACULAR HOLE. | Retina | 2023 | 37040605 | PubTator, text mining | PubMed |
| Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy. | Circ Genom Precis Med | 2023 | 37039013 | PubTator, text mining | PubMed |
| Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer. | Invest New Drugs | 2023 | 37036582 | PubTator, text mining | PubMed |
| Editorial: Eye in systemic diseases. | Front Med (Lausanne) | 2023 | 37035311 | PubTator, text mining | PubMed |
| Microscope integrated OCT (Mi-OCT) guided retrieval of intrastromal corneal foreign body. | GMS Ophthalmol Cases | 2023 | 37034412 | PubTator, text mining | PubMed |
| Empirical retinal venous pulse wave velocity using modified photoplethysmography. | BMC Res Notes | 2023 | 37031176 | PubTator, text mining | PubMed |
| Amniogenesis in Human Amniotic Sac Embryoids after Exposures to Organophosphate Flame Retardants. | Environ Health Perspect | 2023 | 37027338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=30